Mitchell P. Kopin 13D/13G Filings for Can-Fite BioPharma Ltd. (CANF)

Mitchell P. Kopin 13D and 13G filings for Can-Fite BioPharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
06:52 am
Purchase
2021-12-3113GCAN-FITE BIOPHARMA LTD SPONSOR
CANF
Mitchell P. Kopin197,477
4.990%
32,919increase
(+20.00%)
Filing